Gilead Sciences
GILD
1,438 hedge funds and large institutions have $120B invested in Gilead Sciences in 2014 Q4 according to their latest regulatory filings, with 216 funds opening new positions, 604 increasing their positions, 518 reducing their positions, and 90 closing their positions.
140% more first-time investments, than exits
New positions opened: 216 | Existing positions closed: 90
17% more repeat investments, than reductions
Existing positions increased: 604 | Existing positions reduced: 518
8% more funds holding
Funds holding: 1,326 → 1,438 (+112)
13% less capital invested
Capital invested by funds: $139B → $120B (-$18.6B)
18% less funds holding in top 10
Funds holding in top 10: 240 → 196 (-44)
32% less call options, than puts
Call options by funds: $3.07B | Put options by funds: $4.55B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
+$811M |
| 2 |
Bank of New York Mellon
New York
|
+$531M |
| 3 |
Goldman Sachs
New York
|
+$325M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$266M |
| 5 |
State Street
Boston,
Massachusetts
|
+$256M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$2.53B |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$1.63B |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$756M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$619M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$552M |
GILD Hedge Fund Activity: Q4 2014 in Review
1,438 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2014, worth a combined $120B — down 13% from $139B a quarter earlier.
Buyers outnumbered sellers: 216 funds opened new GILD positions and 90 closed out — a net gain of 126 holders — while 604 added to existing stakes and 518 trimmed.
The largest buyer was Temasek Holdings, adding an estimated $811M. The largest seller was Capital Research Global Investors, cutting an estimated $2.53B.
- 1,438 institutional investors held Gilead Sciences (GILD) as of Q4 2014, up from 1,326 in Q3 2014.
- Funds reported $120B of Gilead Sciences stock for Q4 2014, down 13% quarter-over-quarter.
- 216 funds opened new Gilead Sciences positions in Q4 2014 and 90 closed out, a net change of +126 holders.
- The largest Gilead Sciences buyer in Q4 2014 was Temasek Holdings, an estimated $811M added.
- The largest Gilead Sciences seller in Q4 2014 was Capital Research Global Investors, an estimated $2.53B sold.
Based on aggregated 13F filings for Q4 2014.